Contact

Connect with us

BioSyngen is developing multiple T-cell immunotherapies with the aim to address a wide range of malignancies.

SINGAPORE HEADQUATERS

Park Avenue
Rochester

31 Rochester Drive, #02-57/58
Park Avenue Rochester, Singapore 138637

GUANGZHOU, CHINA

1-3F., Block B, Building 6, Chuangyan Street, Sino-Singapore Knowledge City, Huangpu District, Guangzhou, P. R. China

WRITE TO US